PRAC Starts Safety Overview of Remdesivir

Editor’s imprint: Procure the most modern COVID-19 details and guidance in Medscape’s Coronavirus Resource Center. Reports of acute kidney hurt in some sufferers with COVID-19 receiving remdesivir (Veklury, Gilead Sciences) bask in introduced on the Pharmacovigilance Threat Evaluate Committee (PRAC)…